Vernalis Research
| Company type | Subsidiary |
|---|---|
| Industry | Pharmaceutical and Biotechnology |
| Predecessor | Vernalis plc |
| Founded | 2018 |
| Headquarters | , |
Key people | Clare Searle (Finance Director) James Murray (Research Director) |
| Products | Pharmaceuticals |
| Owner | Vernalis (R&D) Limited |
Number of employees | 75 |
| Parent | HitGen |
| Website | vernalis.com |
Vernalis Research develops and applies fragment and structure-based methods to drug discovery, and has generated cell active lead compounds and development candidates against biological targets in oncology, neurodegeneration, anti-infectives and inflammation.